Not So Different: A Podcast From The Center For Biosimilars
S3 Ep14: Byoungseo Choi on Celltrion's Biosimilar Goals For 2030
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:57
- Mas informaciones
Informações:
Sinopsis
To learn more about Celltrion Healthcare, visit celltrionhealthcare.com. You can learn more about the testing of Celltrion's infliximab biosimilar for the treatment of COVID-19 here.
